• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, April 24, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Yōni.Fit® Bladder Support for Stress Urinary Incontinence Expands Indication to Include Menstrual Health

Bioengineer by Bioengineer
April 24, 2026
in Health
Reading Time: 4 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Watkins-Conti Products, Inc., a pioneering enterprise focused on advancing women’s pelvic health, has announced a landmark expansion of the application for its innovative flagship device, the Yōni.Fit Bladder Support. This breakthrough represents the first FDA-approved dual-purpose vaginal insert that not only manages stress urinary incontinence (SUI) but also collects menstrual fluid and vaginal discharge, addressing a substantial unmet clinical need for active women experiencing these common yet often under-discussed conditions.

The Yōni.Fit device, constructed from 100% medical-grade silicone and manufactured entirely within the United States, is designed to be soft and flexible, facilitating comfortable self-insertion and removal. It is offered in six distinct sizes to accommodate variations in anatomy and is available either through healthcare provider prescription or directly online. This accessibility ensures broader reach and empowers women to manage their pelvic health proactively without the burden of invasive procedures or external devices.

Stress urinary incontinence—a condition characterized by involuntary urine leakage triggered by increased intra-abdominal pressure during activities such as physical exertion, coughing, or laughing—affects approximately two-thirds of women in the United States at some point in their lives. The impact on quality of life can be profound, influencing social engagement, psychological wellbeing, and even physical health. Prior to the Yōni.Fit, options for SUI were often limited to absorbent products that do not address the cause and can be inconvenient and uncomfortable. The Yōni.Fit’s FDA clearance in 2024 for up to 12 hours of continuous use marked a significant advancement in non-invasive SUI management.

The recent FDA labeling expansion of Yōni.Fit is a game-changer in the realm of menstrual hygiene, particularly for women who also experience stress urinary incontinence. The device now officially supports the safe collection of menstrual fluid and vaginal discharge alongside managing bladder leakage during menstruation. This innovation aligns with increasing user interest in menstrual cups, which are gaining popularity for their eco-friendly profile, reusability, and cost-effectiveness. Harvard Chan School of Public Health research indicates that around 20% of menstruating women in the U.S. currently use menstrual cups, especially those aged 18 to 35.

Clinical evidence supporting Yōni.Fit’s efficacy is robust, stemming from randomized, controlled, single-blind, multi-center trials involving women diagnosed with SUI. The device achieved over 96% reduction in clinically significant bladder leaks, underscoring its reliability and effectiveness as a pelvic health tool. Adverse effects reported were minor to moderate in severity, with no serious device-related complications, affirming Yōni.Fit’s safety profile for everyday use.

Clinicians specializing in urogynecology and reconstructive pelvic surgery endorse the device’s expanded utility. According to Dr. Karolynn Echols, a principal investigator in the clinical trials and Associate Professor at Thomas Jefferson University, Yōni.Fit offers patients a unique self-care option that extends beyond traditional incontinence products by integrating menstrual fluid management. Such dual functionality reduces reliance on disposable pads and tampons, which have detrimental environmental footprints.

Founder and CEO Allison L. Watkins emphasizes the longstanding demand from women for a versatile solution that addresses multiple leakages simultaneously. She highlights the device’s role in advancing environmental sustainability while maintaining clinical efficacy and user comfort. Watkins-Conti’s innovation underlines a trend toward patient-centered design in medical devices that deeply understand users’ lived experiences.

Given the device’s prescription status and inclusion in Health Savings Account (HSA) eligibility, Yōni.Fit may be covered under select insurance plans, improving affordability. Healthcare providers can easily integrate the device into their practice through specialized stocking options provided by Watkins-Conti, which supports a smooth prescribing and supply chain experience.

The company’s strategic vision extends well beyond the Yōni.Fit, aiming to build a comprehensive pipeline of pelvic health innovations backed by a strong intellectual property portfolio. With multiple U.S. and international patents, Watkins-Conti is securing its position at the forefront of women’s healthcare technologies, focused on delivering clinical solutions that are both accessible and effective.

In conclusion, the expanded FDA clearance of Yōni.Fit as both an SUI treatment and a menstrual fluid collector marks a significant milestone in female pelvic health innovation. This development not only enhances the quality of life for millions of women but also contributes to environmental sustainability and women’s autonomy over their bodies. Offerings such as Yōni.Fit represent the next generation of pelvic health solutions, blending clinical sophistication with practical usability in everyday life.

Subject of Research: Women’s pelvic health devices, stress urinary incontinence, menstrual fluid management
Article Title: Watkins-Conti’s Yōni.Fit: Revolutionizing Pelvic Health with Dual-Use Vaginal Insert
News Publication Date: April 23, 2026
Web References:

Home Copy

Menstrual hygiene products: pads and tampons are the go-to choice


https://journals.lww.com/fpmrs/Abstract/2022/04000/Updated_Prevalence_of_Urinary_Incontinence_in.1.aspx
https://journals.lww.com/fpmrs/fulltext/9900/a_randomized_controlled_trial_of_a_novel_device.383.aspx
Image Credits: Watkins-Conti Products, Inc.
Keywords: stress urinary incontinence, pelvic health, menstrual fluid management, vaginal insert, Yōni.Fit, FDA clearance, women’s health innovation, urogynecology, medical-grade silicone, menstrual cup alternative

Tags: accessible pelvic health solutionsFDA-approved dual-purpose vaginal devicemedical-grade silicone vaginal insertmenstrual fluid collection devicemenstrual health technologynon-invasive urinary incontinence treatmentpelvic floor support for womenself-insertion vaginal devicestress urinary incontinence managementvaginal insert for pelvic healthwomen’s pelvic health innovationYōni.Fit bladder support device

Share12Tweet7Share2ShareShareShare1

Related Posts

Immune Surveillance Structures Identified in Skin Hair Follicles

April 24, 2026

University of Cincinnati Collaborates with Local Paramedics to Propel Sudden Cardiac Arrest Research

April 24, 2026

Mount Sinai Study Reveals How Early-Life Metal Exposure Influences Brain Development and Behavior Using Baby Teeth and Brain Imaging

April 24, 2026

Anti-Vaping Campaigns and Lung Injury Reports Drive Decline in Teen Vaping, Study Finds

April 24, 2026

POPULAR NEWS

  • Research Indicates Potential Connection Between Prenatal Medication Exposure and Elevated Autism Risk

    817 shares
    Share 327 Tweet 204
  • New Study Reveals Plants Can Detect the Sound of Rain

    655 shares
    Share 262 Tweet 164
  • Scientists Investigate Possible Connection Between COVID-19 and Increased Lung Cancer Risk

    66 shares
    Share 26 Tweet 17
  • Salmonella Haem Blocks Macrophages, Boosts Infection

    60 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

New Study Finds Maternal Dairy Intake Within Guidelines Linked to Reduced Levels of Certain Human Milk Lipids

RagC Detects β-Hydroxybutyrate Levels to Inhibit mTORC1 Activity and Tumor Progression

Nanoscale Nuclear Organization Revealed by High-Resolution Imaging

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 81 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.